Provided by Tiger Fintech (Singapore) Pte. Ltd.

AEON Biopharma

0.7273
-0.0075-1.02%
Volume:99.97K
Turnover:71.65K
Market Cap:8.22M
PE:0.01
High:0.7274
Open:0.7200
Low:0.7029
Close:0.7348
Loading ...
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 24, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Oct 23, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Oct 19, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 23, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 19, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 14, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 01, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jul 28, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jul 27, 2023

Major Issues Report

Form 8-K - Current report
Jul 24, 2023

Major Issues Report

Form 8-K - Current report
Jul 21, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 21, 2023

Voluntary Delisting

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Jul 20, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jul 17, 2023

Major Issues Report

Form 8-K - Current report
Jul 17, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 12, 2023

Major Issues Report

Form 8-K - Current report